Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases; a new simplified technique in isolated hepatic perfusion

Keyphrases

• Melphalan 100%
• Liver Metastasis 100%
• Simplified Method 100%
• Hepatic Perfusion 100%
• Isolated Hepatic Perfusion 100%
• Metastasis 66%
• Blood Loss 66%
• Treatment Options 33%
• High-dose Chemotherapy 33%
• Pharmacokinetics 33%
• Liver 33%
• Consecutive Patients 33%
• Response Rate 33%
• Median Time 33%
• Tumor Response 33%
• Stable Disease 33%
• Partial Response 33%
• Local Control 33%
• Complete Response 33%
• Simple Procedure 33%
• Cost Reduction 33%
• Tumor Control 33%
• Postoperative Mortality 33%
• Operative Time 33%
• Time to Progression 33%
• Occlusion 33%
• Perfusion 33%
• Systemic Toxicity 33%
• Portal Vein 33%
• Systemic Concentration 33%
• Hepatic Artery 33%
• Heart-lung Machine 33%
• Caval Veins 33%
• Leakage Monitoring 33%
• Local Impacts 33%
• Material Cost 33%
• Personnel Costs 33%

Medicine and Dentistry

• Health Care Cost 100%
• Melphalan 100%
• Liver Metastasis 100%
• Neoplasm 66%
• Metastatic Carcinoma 66%
• Bleeding 66%
• Disease 33%
• High Dose Chemotherapy 33%
• Pharmacokinetics 33%
• Operation Duration 33%
• Common Hepatic Artery 33%
• Vasoactive Agent 33%
• Hepatic Portal Vein 33%
• Venae cavae 33%
• Lung 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Melphalan 100%
• Liver Metastasis 100%
• Neoplasm 66%
• Bleeding 66%
• Disease 33%
• High Dose Chemotherapy 33%
• Vasoactive Agent 33%
• Pharmacokinetics 33%